(Total Views: 1236)
Posted On: 10/04/2020 7:36:17 AM
Post# of 154138
Re: Shelly2626 #59550
Yup,
We are getting a full load of free publicity in MABs ...
Can't ask for more apart from specific mention of Leronlimab. The press will continue "analyzing" and commenting on what was used ad nauseam for the next weeks.
And then, here we come !!!!
Next weeks we should have some news as there is time enough for the statistician to run the numbers. It will be, of course a STOP or a CONTINUE. Just hoping for the former but wishing as well our CD12 enrollment is going forward full speed.
We will arrive there
We are getting a full load of free publicity in MABs ...
Can't ask for more apart from specific mention of Leronlimab. The press will continue "analyzing" and commenting on what was used ad nauseam for the next weeks.
And then, here we come !!!!
Next weeks we should have some news as there is time enough for the statistician to run the numbers. It will be, of course a STOP or a CONTINUE. Just hoping for the former but wishing as well our CD12 enrollment is going forward full speed.
We will arrive there
(5)
(0)
